MediRX Tirzepatide Review: Cost, a Self-Hosted LegitScript Badge & Honest Verdict (2026)

MediRX: it links to a LegitScript checker page, but the badge image itself is self-hosted ("/icons/legit-certification.png") rather than served from LegitScript's own CDN — a weaker verification pattern than sites whose seal this review could confirm directly against LegitScript's servers. Every fact here comes from the company's own published program.

A self-hosted LegitScript badge

This review checked MediRX's LegitScript claim directly: the site links out to legitscript.com/websites/medirx.org, which is a real checker URL. But unlike providers whose badge image this review could verify was served from static.legitscript.com — LegitScript's own CDN — MediRX's badge is a self-hosted image file. That doesn't mean the certification is false, but it means the badge itself can't be independently confirmed as authentic the way a CDN-served seal can; the checker link is the more reliable signal here.

What MediRX is

MediRX (MediRX, Inc., Wyoming) is a telehealth weight-loss platform, offering compounded GLP-1 injections plus NAD+ and a name-brand GLP-1 option. Care and pharmacy fulfillment run on OpenLoop Health's licensed network — a real, named clinical infrastructure provider rather than an unnamed "licensed pharmacy network."

What MediRX costs

Semaglutide starts at $149/month and tirzepatide at $199/month, with a low promotional first-month price (semaglutide as low as $70 the first month). The ongoing monthly price rises after the promotional first month, so confirm your month-two price before committing.

The brand-vs-compounded question

MediRX offers compounded injections plus a name-brand GLP-1 option — limited oral options. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials; the brand option is the exact molecule and dose that was. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

MediRX's real strengths: a named operating entity (MediRX, Inc., Wyoming), a named clinical infrastructure partner (OpenLoop Health), and a low promotional first-month price, all or. The trade-offs: a self-hosted LegitScript badge this review couldn't verify against the CDN seal, an ongoing price that rises after the promotional first month, no published list of served states, and specific compounding pharmacies not named beyond the OpenLoop network. As with any GLP-1 program, confirm your month-two price and state coverage directly; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

MediRX's named entity and named OpenLoop fulfillment partner are real transparency signals, but this review found its LegitScript badge is self-hosted rather than CDN-verified, and the promotional first-month price rises afterward. Confirm your ongoing price before committing. For a provider with a genuinely verified LegitScript seal against the issued image, see MedLeanRx or Luvo Health. See our best tirzepatide providers ranking for the full field.